Class summary at a glance.

Every drug in the Provitamin D2 Compound class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 5tracked in Part D
CY24 Part D spend: $20.2Mcombined across class
Total Rx claims: 2.5M967K unique beneficiaries
Generic mfrs (active): 4across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Ergocalciferol (Vitamin D2)

2.5M Part D claims (CY24) · 967K beneficiaries · First FDA approval: 2018-12-10

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend $20.2M

Class share

100%

of class CY24 spend

View profile →

Ergocalciferol

Brand: VITAMIN D · — Part D claims (CY24) · First FDA approval: 2010-08-03

4 generic mfrs

Low NADAC$0.116

→

Avg plan cost$0.116

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Ergocalciferol Capsules,

Brand: Ergocalciferol · — Part D claims (CY24) · First FDA approval: 2018-12-10

Brand-only (no generics)

Low NADAC$0.116

→

Avg plan cost$0.116

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Vitamin A Palmitate, Ergocalciferol, .Alpha.-Tocopherol, Dl-, Phytonadione

Brand: Vitalipid N · — Part D claims (CY24) · First FDA approval: 2023-08-18

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Vitamin D

— Part D claims (CY24) · First FDA approval: 2019-03-19

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.